Home LiteratureArticle Details
PMID: 10716257 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Association of interleukin-1 gene polymorphisms with Alzheimer's disease.

Annals of neurology ·Vol. 47 ·No. 3 ·2000-03-00 ·Pages 365-8

Nicoll JA, Mrak RE, Graham DI, Stewart J, Wilcock G, MacGowan S, Esiri MM, Murray LS, Dewar D, Love S, Moss T, Griffin WS

Abstract

Interleukin-1 (IL-1) is markedly overexpressed in Alzheimer's disease. We found the IL-1A 2,2 genotype in 12.9% of 232 neuropathologically confirmed Alzheimer's disease patients and 6.6% of 167 controls from four centers in the United Kingdom and United States (odds ratio, 3.0; controlled for age and for ApoE [apolipoprotein E] genotype). Homozygosity for both allele 2 of IL-1A and allele 2 of IL-1B conferred even greater risk (odds ratio, 10.8). IL-1 genotypes may confer risk for Alzheimer's disease through IL-1 overexpression and IL-1-driven neurodegenerative cascades.

MeSH Terms
Aged Aged, 80 and over Alleles Alzheimer Disease/genetics Genotype Humans Interleukin-1/genetics Polymorphism, Genetic/genetics
Chemicals
Interleukin-1
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Nicoll J A
Department of Neuropathology, Institute of Neurological Sciences, Southern General Hospital, Glasgow, Scotland.
Mrak R E
Graham D I
Stewart J
Wilcock G
MacGowan S
Esiri M M
Murray L S
Dewar D
Love S
Moss T
Griffin W S
References (20)
20 references, click to expand
  1. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor.
    Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10075-8 PMID: 1359534
  2. A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes.
    Genomics. 1994 Jan 15;19(2):382-4 PMID: 8188271
  3. Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury.
    Nat Med. 1995 Feb;1(2):135-7 PMID: 7585009
  4. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene.
    Nature. 1995 Aug 31;376(6543):775-8 PMID: 7651536
  5. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease.
    Nature. 1995 Jun 29;375(6534):754-60 PMID: 7596406
  6. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism.
    Arthritis Rheum. 1995 Feb;38(2):221-8 PMID: 7848312
  7. Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression.
    Neurosci Lett. 1994 Aug 1;176(2):133-6 PMID: 7830934
  8. Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.
    Neurology. 1994 Feb;44(2):227-32 PMID: 8309563
  9. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.
    Neurology. 1993 Aug;43(8):1467-72 PMID: 8350998
  10. Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1.
    Brain Res Mol Brain Res. 1992 Nov;16(1-2):128-34 PMID: 1334190
  11. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro.
    Eur J Clin Invest. 1992 Jun;22(6):396-402 PMID: 1353022
  12. Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group.
    Int J Epidemiol. 1991;20 Suppl 2:S28-35 PMID: 1833351
  13. Apolipoprotein E genotyping by one-stage PCR.
    Lancet. 1991 May 11;337(8750):1158-9 PMID: 1674030
  14. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.
    Neurology. 1991 Apr;41(4):479-86 PMID: 2011243
  15. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.
    Nature. 1991 Feb 21;349(6311):704-6 PMID: 1671712
  16. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
    Proc Natl Acad Sci U S A. 1989 Oct;86(19):7611-5 PMID: 2529544
  17. Translation of the alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5'-untranslated region sequences.
    J Biol Chem. 1999 Mar 5;274(10):6421-31 PMID: 10037734
  18. Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression.
    Brain Pathol. 1998 Jan;8(1):65-72 PMID: 9458167
  19. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E.
    Nature. 1997 Aug 28;388(6645):878-81 PMID: 9278049
  20. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis.
    Neurobiol Aging. 1996 Sep-Oct;17(5):761-6 PMID: 8892349
Article Info
Journal
Annals of neurology
Abbr.
Ann Neurol
ISSN
0364-5134
Published
2000-03-00
Pages
365-8
Language
English
Region
United States
NLM ID
7707449
PMCID
PMC3833599
Subset
IM
Grants
Wellcome Trust · United Kingdom
NIA NIH HHS · P01 AG012411 · United States
NIA NIH HHS · AG10208 · United States
NIA NIH HHS · AG12411 · United States
Corrections
CommentIn
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com